On 10 April 2024 the European Parliament adopted its position on the draft text on the revision of the European Union’s (EU) general pharmaceutical legislation, also referred to as the (proposed) “EU ...

On 4 June 2025, the Council of the EU adopted its position on the EU Pharma Law Package legislative proposal to revise the EU’s general pharmaceutical legislation. The Council, consisting of all the ...

“The fact that Brazil is considering debating this topic is encouraging news. While proponents of RDP argue that this measure is necessary to protect investments in innovation in the pharmaceutical ...

If there was one theme that defined financial services in 2025, it was purpose-led regulation. Beyond product expansion and ...

The recent introduction of the American Privacy Rights Act of 2024 (APRA) by Senate Commerce Committee Chair Senator Maria Cantwell (D-Wash.) and House Energy and ...

The Council is ready to begin negotiations with the European Parliament, having agreed its position on new rules that aim to make the EU’s pharmaceutical sector fairer and more competitive. The ...

Marco Stief of Maiwald considers a regulatory proposal designed to promote antimicrobial R&D and address the ineffectiveness of patent protection, but points out that the proposal lacks clarity and ...

While most of Europe was still knuckle deep in the holiday chocolate selection box late last month, ChatGPT maker OpenAI was busy firing out an email with details of an incoming update to its terms ...

Regulatory compliance is a core part of business operations for companies in every sector. Organisations must keep up with a ...

The use of AI frequently leads to uncertainties for public bodies. The latest publication by the Federal Commissioner for Data Protection provides a remedy.

As AI continues to transform industries, the conversation around AI regulation has intensified. However, one crucial aspect often overlooked in these discussions is the foundational role of data ...